These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 21242971)

  • 1. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
    Yu F; Li J; Chen H; Fu J; Ray S; Huang S; Zheng H; Ai W
    Oncogene; 2011 May; 30(18):2161-72. PubMed ID: 21242971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Krüppel-like Factor 4-p21
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2019 Mar; 12(3):125-134. PubMed ID: 30723175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.
    Yori JL; Seachrist DD; Johnson E; Lozada KL; Abdul-Karim FW; Chodosh LA; Schiemann WP; Keri RA
    Neoplasia; 2011 Jul; 13(7):601-10. PubMed ID: 21750654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression.
    Yori JL; Johnson E; Zhou G; Jain MK; Keri RA
    J Biol Chem; 2010 May; 285(22):16854-63. PubMed ID: 20356845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cells.
    Yu F; Shi Y; Wang J; Li J; Fan D; Ai W
    Int J Cancer; 2013 Dec; 133(12):2872-83. PubMed ID: 23737434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.
    Okuda H; Xing F; Pandey PR; Sharma S; Watabe M; Pai SK; Mo YY; Iiizumi-Gairani M; Hirota S; Liu Y; Wu K; Pochampally R; Watabe K
    Cancer Res; 2013 Feb; 73(4):1434-44. PubMed ID: 23384942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
    Lee HK; Lee DS; Park JC
    BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion.
    Korkaya H; Paulson A; Iovino F; Wicha MS
    Oncogene; 2008 Oct; 27(47):6120-30. PubMed ID: 18591932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29a-KLF4 signaling inhibits breast tumor initiation by regulating cancer stem cells.
    Zhao Q; Shang Y; Lü J; Liu Y; Wang T; Li D; Li J; Lu Y; Wang Z; Yu Z
    Int Immunopharmacol; 2024 Mar; 130():111797. PubMed ID: 38442582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer.
    Jia Y; Zhou J; Luo X; Chen M; Chen Y; Wang J; Xiong H; Ying X; Hu W; Zhao W; Deng W; Wang L
    Cell Signal; 2018 Jan; 42():165-175. PubMed ID: 28988130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cells.
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2014 Jul; 7(7):738-47. PubMed ID: 24824039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
    Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
    Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
    Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
    Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4.
    Wang R; Yu W; Zhu T; Lin F; Hua C; Ru L; Guo P; Wan X; Xue G; Guo Z; Han S; Lv K; Zhang G; Ge H; Guo W; Xu L; Deng W
    Cancer Sci; 2023 Jun; 114(6):2277-2292. PubMed ID: 36786527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Kruppel-like factor 4 regulates angiogenesis and the Notch signaling pathway.
    Hale AT; Tian H; Anih E; Recio FO; Shatat MA; Johnson T; Liao X; Ramirez-Bergeron DL; Proweller A; Ishikawa M; Hamik A
    J Biol Chem; 2014 Apr; 289(17):12016-12028. PubMed ID: 24599951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.